SUPPORTING INFORMATION:

Similar documents
A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

Automated Sample Preparation/Concentration of Biological Samples Prior to Analysis via MALDI-TOF Mass Spectroscopy Application Note 222

Edgar Naegele. Abstract

Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes

Supporting Information for: Daniel Knappe, Stefania Piantavigna, Anne Hansen, Adam Mechler, Annegret Binas,

ANALYTICAL REPORT 1 3C-P (C14H23NO3) 1-(3,5-dimethoxy-4-propoxylphenyl)propan-2-amine.

Mechanistic Insight into Oxidized N,N-Dimethylacetamide as a source of Formaldehyde Related Process Derivatives

Electronic Supplementary Information

Analysis of Peptides via Capillary HPLC and Fraction Collection Directly onto a MALDI Plate for Off-line Analysis by MALDI-TOF

Triptycene-Based Small Molecules Modulate (CAG) (CTG) Repeat Junctions

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

ANALYTICAL REPORT 1. N-methyl-2AI ( C10H13N) Remark other NPS detected: none. N-methyl-2,3-dihydro-1H-inden-2-amine. Sample ID:

Lipidomic Analysis by UPLC-QTOF MS

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )

UniChemo Protection: A Novel Concept For Chemical Synthesis. Les P. Miranda and Morten Meldal

Mass Spectrometry at the Laboratory of Food Chemistry. Edwin Bakx Laboratory of Food Chemistry Wageningen University

ANALYTICAL REPORT 1 DPT (C16H24N2) [2-(1H-indol-3-yl)ethyl]dipropylamine.

A Stable Evans Blue Derived Exendin-4 peptide for Type 2 Diabetes Treatment

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

ANALYTICAL REPORT 1, 2

ANALYTICAL REPORT 5F-MDMB-PINACA (C20H28FN3O3) methyl 2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanoate

Antoine Bouchoux, Pierre-Emerson Cayemitte, Julien Jardin, Geneviève Gésan-Guiziou, and Bernard Cabane

ANALYTICAL REPORT 1. bk-2c-b ( C10H12BrNO3) 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one

Dikma Technologies Inc.

Comprehensive Two-Dimensional HPLC and Informative Data Processing for Pharmaceuticals and Lipids

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

Ion Source. Mass Analyzer. Detector. intensity. mass/charge

Mass Spectrometry. Actual Instrumentation

ANALYTICAL REPORT 1, 2

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Authors. Abstract. Introduction. Environmental

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

SUPPLEMENTARY INFORMATION

CHAPTER-6 IDENTIFICATION, AND CHARACTERISATION OF DEGRADATION IMPURITY IN VALSARTAN TABLETS

SUPPLEMENTARY INFORMATION

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Matrix Assisted Laser Desorption Ionization Time-of-flight Mass Spectrometry

Development of a High Sensitivity SPE-LC-MS/MS Assay for the Quantification of Glucagon in Human Plasma Using the ionkey/ms System

Impact of Reversed-Phase Chiral Chromatography on the LC-MS Analysis of Drugs in Biological Fluids

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

Supporting Information

Restek Ultra II HPLC Columns

SUMMARY, CONCLUSION & RECOMMENDATIONS

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Supporting information

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

High Resolution Glycopeptide Mapping of EPO Using an Agilent AdvanceBio Peptide Mapping Column

Comparison of a UPLC Method across Multiple UHPLC Systems

Dikma Technologies Inc.

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography

Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations

application Natural Food Colorants Analysis of Natural Food Colorants by Electrospray and Atmospheric Pressure Chemical Ionization LC/MS

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

Analysis of Pesticides (II) Metribuzin & their metabolites in Rice Jun Yonekubo, Nihon Waters, JAPAN

SUPPORTING INFORMATION TO: Oligonucleotide cyclization: The thiol-maleimide reaction revisited. Albert Sánchez, Enrique Pedroso, Anna Grandas*

Components of a Mass Spectrometer

Dienes Derivatization MaxSpec Kit

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Thermo Scientific. GlycanPac AXR-1. Column Product Manual. P/N: April, Part of Thermo Fisher Scientific

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

LC-Based Lipidomics Analysis on QTRAP Instruments

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Gerry Hendrickx Regional Sales Manager Central Europe. Developments in Waters Column Chemistries : BEH Technology

High-Throughput Analysis of Oligonucleotides using Automated Electrospray Ionization Mass Spectrometry

The LC Column Playbook

Analysis of Food Sugars in Various Matrices Using UPLC with Refractive Index (RI) Detection

VaTx1 VaTx2 VaTx3. VaTx min Retention Time (min) Retention Time (min)

Development of a Cell-penetrating Peptide that Exhibits Responsive. Changes in its Secondary Structure in the Cellular Environment

Application Note. Abstract. Authors. Pharmaceutical

Pelagia Research Library

The Raptor HILIC-Si Column

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Reaction Screening and Optimization of Atropine Synthesis in Continuous-Flow Guided by Preparative Electrospray

STANDARD OPERATING PROTOCOL (SOP)

4-Fluoroethamphetamine

Matrix-induced Signal Enhancement of Propamocarb in LC-MS/MS

1. Sample Introduction to MS Systems:

Electronic Supporting Information

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Eszopiclone (Lunesta ): An Analytical Profile

Core E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley

Supporting Information. Scale-up synthesis of tesirine

Unique Retention and Selectivity of Pentafluorophenylpropyl Phases for High-Throughput LC/MS Analysis

ANALYTICAL REPORT. 1-(1,3-diphenylpropan-2-yl)pyrrolidine (C19H23N) 1-(1,3-diphenylpropan-2-yl)pyrrolidine

2. REVIEW OF LITERATURE

Systematic Evaluation of Solid Phase Extraction (SPE) Chemistries for the Determination of Acidic, Neutral, and Basic Drugs

Ionization Methods. Neutral species Charged species. Removal/addition of electron(s) Removal/addition of proton(s)

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Supporting information for: Memory Efficient. Principal Component Analysis for the Dimensionality. Reduction of Large Mass Spectrometry Imaging

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

for the Identification of Phosphorylated Peptides

Transcription:

1S SUPPORTING INFORMATION: The discovery of the once weekly glucagon like peptide 1 (GLP-1) analog semaglutide Jesper Lau*, Paw Bloch, Lauge Schäffer, Ingrid Pettersson, Jane Spetzler, Jacob Kofoed, Kjeld Madsen, Lotte Bjerre Knudsen, James McGuire, Dorte Bjerre Steensgaard, Holger Martin Strauss, Dorte X. Gram, Sanne Moller Knudsen, Flemming Seier Nielsen, Peter Thygesen, Steffen Reedtz-Runge and Thomas Kruse. Contents of supporting information: 2S - 8S: 9S 13S: Mass spectrometric methods and data. UPLC methods and data used for purity analysis.

2S Mass spectrometric methods and data. MALDI-TOF: Molecular weights of the peptides were determined using matrix-assisted laser desorption time of flight mass spectroscopy (MALDI-MS), recorded on a Microflex (Bruker). A matrix of alfa-cyano-4-hydroxy cinnamic acid was used. Or altenatively with electrospray ionization using the system stated in the scheme and according to the list below: Agilent TOF: An Agilent Technologies LC/MSD TOF (G1969A) mass spectrometer was used to identify the mass of the sample after elution from an Agilent 1200 series HPLC system. The de-convolution of the protein spectra was calculated with Agilent s protein confirmation software. Eluents: A: 0.1% Trifluoro acetic acid in water; B: 0.1% Trifluoro acetic acid in acetonitrile. Column: Zorbax 5u, 300SB-C3, 4.8x50mm. Gradient: 25% - 95 % B over 15 min. Sciex3000 A Perkin Elmer Sciex API 3000 mass spectrometer was used to identify the mass of the sample after elution from a Perkin Elmer Series 200 HPLC system. Eluents: A: 0.05% Trifluoro acetic acid in water; B: 0.05% Trifluoro acetic acid in acetonitrile. Column: Waters Xterra MS C-18 X 3 mm id 5 µm. Gradient: 5% - 90 % B over 7.5 min at 1.5ml/min LCT premier Performed on a setup consisting of Waters Acquity UPLC system and LCT Premier XE mass spectrometer from Micromass. Eluents: A: 0.1% Formic acid in water; B: 0.1% Formic acid in acetonitrile The analysis was performed at RT by injecting an appropriate volume of the sample (preferably 2-10µl) onto the column which was eluted with a gradient of A and B.The UPLC conditions, detector settings and mass spectrometer settings were: Column: Waters Acquity UPLC BEH, C-18, 1.7µm, 2.1mm x 50mm. Gradient: Linear 5% - 95% acetonitrile during 4.0 min (alternatively 8.0 min) at 0.4ml/min. Detection: 214 nm (analogue output from TUV (Tunable UV detector)) MS ionisation mode: API-ES; Scan: 100-2000 amu (alternatively 500-2000 amu), step 0.1 amu. Sciex 100 or 150 was performed on a setup consisting of Sciex API 100 (or150) Single quadropole mass spectrometer, Perkin Elmer Series 200 Quard pump,perkin Elmer Series 200 autosampler, Applied Biosystems 785A UV detector, Sedex 75 evaporative light scattering detector.the instrument control and data acquisition were done by the Sciex Sample control software running on a Windows 2000 computer. The HPLC pump is connected to two eluent reservoirs containing: A: 0.05% Trifluoro acetic acid in water B: 0.05% Trifluoro acetic acid in acetonitrile. The analysis is performed at room temperature by injecting an appropriate volume of the sample (preferably

3S 20 l) onto the column which is eluted with a gradient of acetonitrile.the HPLC conditions, detector settings and mass spectrometer settings used are giving in the following table.column: Waters Xterra MS C-18 X 3 mm id 5 um; Gradient: : 5% - 90 % acetonitrile linear during 7.5 min at 1.5ml/min;Detection : 210 nm (analogue output from DAD);ELS (analogue output from ELS), 40 C.MS ionisation mode API-ES.

4S Alalog # MS method Mol Weight Calc. (found) Ions found m/z GLP-1 3355,7 N/A liraglutide 3751,2 (3751) 1876.4 1251.8 938.8 semaglutide 4113,6 (4113) 1372.3 1029.8 1 3383,7 (3384) 1129 847 Sciex 100 2 3779,3 (3779.5) 1260.8 945.9 (LCT Premier); 3 4097,6 1366.7 1025.2 LCT premier 4 3652,1 (3652) 1826,4 1218 914 5 3680,1 (3680) 1840 1228 922 6 4099,6 (4099) 1367.3 1026.2

5S 7 3397,7 (3397) 1133.5 850.3 8 3765,2 (3765) 1883.6 1255.9 LCT premier 9 3926,4 (3926)) 1309,8. Sciex150 10 3910,4 (3910) 1304 979 11 4055,5 (4055) 1352,9 12 4200,7 (4200) 1051,7 1401,1 13 4083,6 (4083) 1362 1021 14 4111,6 1371.4 1028.9 LCT premier 15 4029,4 (4029) 1344 1009 16 4057,5 (4056) 1353 1015 17 3956,4 (3956) 1319,8

6S 18 4085,5 (4086) 1363 1022 19 3694,2 (3693) 1232 924 20 3823,3 (3824) 1275.8 957.3 21 3968,4 (3968) 1984.6 1232.3 992.9 22 4113,6 (4113) 1372 1029 23 4112,6 (4112) 1371.7 1029.0 924.5 MALDI-TOF 24 alpha-cyano-4- hydroxycinnamic acid 4258,7 (4256) 4256 25 4246,8 (4248) 1416.4 1062.5 26 4242,7 (4242) 1415.2 1062 27 4371,8 (4372) 1458.4 1094.3

7S 28 4182,6 (4182) 1395.1 1046.6 837.5 29 4069,6 (4069) 2035.5 1357.4 1018.2 30 4053,5 (4053) 1014.3 1352.1 31 4141,6 (4142) 1036,7 1381,8 32 4169,7 (4169) 1390.7 1043.4 33 3970,4 (3970) 1325 993 34 3970,4 (3970) 993,8 1987,2 35 Agilent TOF 4084,6 (4084.9) 2043.1 1362.4 1022.1

8S 36 Agilent TOF 4114,6 (4114.9 2058.1 1372.4 1029.5 37 3937,5 (3938) 1969 38 MALDI-TOF alpha-cyano-4- hydroxycinnamic acid 4156,7 (4156.8) 4156.8 39 MALDI-TOF alpha-cyano-4- hydroxycinnamic acid 4142,7 (4141,9) 4141,9 40 3694,2 (3694) 924,8 1232,4 1848,2 41 3850,3 3851,1 1284,8 964,0 42 4140,6 (4140,7) 829,5 1036, 1381,3 43 4269,8 (4269) 1423.9 1068.8 855.3 44 4126,6 (4126,7) 1376,6

9S UPLC and HPLC methods used for purity analysis: General methods: The RP-HPLC analysis may be performed using UV detection at 214 nm and e.g. a Vydac 218TP54 4.6mm x 250mm 5 C-18 silica column (The Separations Group, Hesperia, USA) and eluted at e.g. 1 ml/min at 42 o C. Most often one of four different elution conditions are used: A1: Equilibration of the column with a buffer consisting of 0.1M (NH 4 ) 2 SO 4, which was adjusted to ph 2.5 with concentrated H 2 SO 4 and elution by a gradient of 0% to 60% CH 3 CN in the same buffer during 50 min. B1: Equilibration of the column with 0.1% TFA / H 2 O and elution by a gradient of 0% CH 3 CN / 0.1% TFA / H 2 O to 60% CH 3 CN / 0.1% TFA / H 2 O during 50 min. B6: Equilibration of the column with 0.1% TFA / H 2 O and elution by a gradient of 0% CH 3 CN / 0.1% TFA / H 2 O to 90% CH 3 CN / 0.1% TFA / H 2 O during 50 min. Alternatively the RP-HPLC analysis was performed using UV detection at 214 nm and a Symmetry300, 3.6mm x 150mm, 3.5 C-18 silica column (Waters) which was eluted at 1 ml/min at 42 o C. B4: Equilibration of the column with 0.05% TFA / H 2 O and elution by a gradient of 5% CH 3 CN / 0.05% TFA / H 2 O to 95% CH 3 CN / 0.05% TFA / H 2 O during 15 min.

10S Analytical methods, HPLC and UPLC Method name Eluent A Eluent B Linear gradient column Column temp C. Run time (min) Flow rate ml/min B4 acetonitrile 1% TFA in water 5-95% Symmetry300 C18, 5 42 15 1 um, 3.9 mm x 150 mm RX acetonitrile 1% TFA in water 5-95% Symmetry300 C18, 5 42 15 1 um, 3.9 mm x 250 mm J acetonitrile 1% TFA in water 20-65% Jupiter proteo C12, 4 42 50 1 um, 4.6 mm x 250 mm B6 acetonitrile 0.1% TFA in water 0-90% Vydac 218TP54 4.6mm x -18 silica column 42 50 1 02 99.95% Acetonitrile, 0.05% Trifluoroacetic acid B2 99.95% Acetonitrile, 0.05% Trifluoroacetic acid 07 20% Isopropanole, 20% Water and 60% Acetonitrile 99.95% Water, 0.05% Trifluoroacetic acid 99.95% Water, 0.05% Trifluoroacetic acid 0.09 M di-ammonium Hydrogen Phosphate (aq) and 10% Acetonitrile, ph 3.6 5-95% ACQUITY UPLC BEH C18, 1.7um, 2.1 mm x 150 mm column 5-60 BEH130, C18, 1.7um, 2.1x150mm Step gradient: 35% B over 2 minutes, then 35% to 65% B over 15 minutes, then 65% to 80% B over 3 minutes and finally 80% B over 1 minute Phenomenex Kinetex C18, 1.7um, 2.1 mm x 150 mm column 40 16 0.4 40 16 0.40 60 23 0.5 A6 80%acetonitrile 10mM TRIS and 15mM ammonium sulphate ph 7.3 in 20%acetonitrile 80% water A3 70 % acetonitrile. A: 90 % H 2 O, 10 % CH 3 CN, 0.25 M ammonium bicarbonate; B: 70 % CH 3 CN, 30 % H 2 O. 5-90 HSS T3, 1.8um, 2.1 mm x 150 mm column 25-55 HSS T3, 1.8um, 2.1 mm x 150 mm column 30 16 0.35 30 16 0.35

11S List of analytical data: Analog # Retention time Purity (min) (%) liraglutide 10.8 100 B4 Method semaglutide 9.6 100 B4 1 10.7 96 B2 2 46.6 97 J 3 11.4 91 B4 4 9.50 97 B4 5 9.89 96 B4 6 11.8 93 B4 7 7.8 100 B4 8 10.6 98 A6 9 35.2 92 B6 10 10.7 95 B4 11 9.9 95 02 12 34.5 100 B6 13 10.7 88 B4 14 11.4 91 B4 15 9.7 96 07 16 8.2 96 B4 17 30.4 99 B6 18 8.4 95 02 19 9.9 91 B4 20 9.6 97 B4 21 14.0 100 A3 22 8.8 91 02 23 8.7 100 02 24 25 32.1 95 B6 26 10.1 100 B4 27 10.7 100 B4 28 29 9.1 100 B4 30 8.87 89.5 02 31 9.6 100 B4 32 10.4 94 B4 33 12.1 100 B4 34 34.0 100 B6

12S 35 12.6 98 A3 36 8.5 99 B4 37 14.6 94 07 38 8.7 11.2 98 93 B4 A3 39 8.3 11.3 94 94 B4 A3 40 11.0 95 B4 41 9.6 99 B4 42 32.4 95 B6 43 9.3 100 B4 44 32.1 98 RX